← Back to Search

Bronchoscopy for Lung Cancer

N/A
Recruiting
Led By Peter Kneuertz, MD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Computed tomography (CT)-scan finding suspicious for lung cancer with nodal metastases
Clinically stable to undergo diagnostic workup by bronchoscopy with endobronchial ultrasound
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Study Summary

This trial is testing how well a needle aspiration guided by endobronchial ultrasound works in getting samples from patients suspected to have lung cancer that has spread to the nodules.

Eligible Conditions
  • Lung Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of samples collected via endobronchial ultrasound-guided transbronchial needle-aspiration with suction

Side effects data

From 2020 Phase 2 trial • 28 Patients • NCT02230189
5%
Pregnancy identified during study enrollment
5%
Increased systolic blood pressure post-bronchoscopy
5%
Respiratory infection post-bronchoscopy
100%
80%
60%
40%
20%
0%
Study treatment Arm
Allergic Asthmatics(AA)
Allergic Non-Asthmatics(ANA)
Non-Allergic Non-Asthmatics(NANA)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Diagnostic (bronchoscopy with EBUS-TBNA with/without vacuum)Experimental Treatment2 Interventions
Patients undergo bronchoscopy with EBUS-TBUA first without and then with applied vacuum.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bronchoscopy
2002
Completed Phase 2
~2270

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
316 Previous Clinical Trials
289,423 Total Patients Enrolled
Peter Kneuertz, MDPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been recruited to take part in this research?

"Indeed, the research posted on clinicaltrials.gov affirms that this trial is currently recruiting participants. It was first announced on August 31st 2020 and its latest update occurred June 13th 2022; 263 patients are required to be enrolled at a single site."

Answered by AI

Is there still capacity available to enroll in this trial?

"According to clinicaltrials.gov, this research project is recruiting volunteers at present. The protocol was originally published on August 31st 2020 and experienced its most recent amendment on June 13th 2022"

Answered by AI
~58 spots leftby Mar 2025